Postoperative Effects of Thiopurines in Patients with Intestinal Behçet’s Disease

[1]  J. Cheon,et al.  An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease , 2015, Current opinion in rheumatology.

[2]  J. Andrews,et al.  Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohn's Disease , 2014, Inflammatory bowel diseases.

[3]  C. Lees,et al.  Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects , 2014, Alimentary pharmacology & therapeutics.

[4]  J. Cheon,et al.  Outcome Predictors for Intestinal Behçet's Disease , 2013, Yonsei medical journal.

[5]  J. Cheon,et al.  The Medical Treatments of Intestinal Behçet's Disease: An Update , 2013 .

[6]  Y. Jung,et al.  Clinical outcomes and prognostic factors for thiopurine maintenance therapy in patients with intestinal Behcet's disease , 2012, Inflammatory bowel diseases.

[7]  Y. Jung,et al.  Prognostic factors and long‐term clinical outcomes for surgical patients with intestinal Behcet's disease , 2011, Inflammatory bowel diseases.

[8]  L. Peyrin-Biroulet,et al.  The use of azathioprine in Crohn’s disease during pregnancy and in the post‐operative setting: a worldwide survey of experts , 2011, Alimentary pharmacology & therapeutics.

[9]  Young Sook Park,et al.  Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet's disease , 2011, Inflammatory bowel diseases.

[10]  L. Peyrin-Biroulet,et al.  Use of azathioprine during pregnancy and in the postoperative setting in Crohn?s disease: A worldwide survey of experts , 2011 .

[11]  M. Geraci,et al.  Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  W. Reinisch,et al.  The Impact of Thiopurines on the Risk of Surgical Recurrence in Patients With Crohn's Disease After First Intestinal Surgery , 2010, The American Journal of Gastroenterology.

[13]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[14]  T. Kim,et al.  Prediction of Free Bowel Perforation in Patients with Intestinal Behçet’s Disease Using Clinical and Colonoscopic Findings , 2010, Digestive Diseases and Sciences.

[15]  Eun Soo Kim,et al.  Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers , 2009, The American Journal of Gastroenterology.

[16]  S. Hanauer,et al.  Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis , 2009, The American Journal of Gastroenterology.

[17]  E. Ebert.  Gastrointestinal Manifestations of Behçet’s Disease , 2009, Digestive Diseases and Sciences.

[18]  P. Rutgeerts,et al.  Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. , 2008, Gastroenterology.

[19]  T. Matsui,et al.  Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach , 2007, Journal of Gastroenterology.

[20]  C. Avellini,et al.  Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. , 2007, Archives of internal medicine.

[21]  F. Obermeier,et al.  Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. , 2006, Gut.

[22]  A. Taschieri,et al.  Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. , 2004, Gastroenterology.

[23]  R. Thisted,et al.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. , 2004, Gastroenterology.

[24]  J. S. Kim,et al.  Long-term clinical course and prognostic factors in intestinal Behçet's Disease , 2000, Diseases of the colon and rectum.

[25]  D. V. van Thiel,et al.  Gastrointestinal manifestations of Behcet's disease. , 2000, Journal of clinical gastroenterology.

[26]  G. Fick,et al.  Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.

[27]  P. Nos,et al.  [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]. , 2000, Gastroenterologia y hepatologia.

[28]  I. Sayek,et al.  Intestinal Behçet's disease: surgical experience in seven cases. , 1991, Hepato-gastroenterology.

[29]  C. Buerk,et al.  Surgical implications of Behçet's disease. , 1980, Archives of surgery.